BIO: Bio-Rad Laboratories Inc. Stocks News on November 21, 2024

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

BIO

Business Wire

4 hours ago

Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference

What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?

BIO

Insider Monkey

8 days ago

What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?

BIO

Argus Research

9 days ago

BIO: Lowering target price to $292.00

BIO

Argus Research

16 days ago

BIO: Raising target price to $299.00

Interpreting Bio-Rad (BIO) International Revenue Trends

BIO

Zacks

17 days ago

Interpreting Bio-Rad (BIO) International Revenue Trends

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

BIO

Simply Wall St.

19 days ago

Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)

BIO

Simply Wall St.

20 days ago

Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)

BIO

Thomson Reuters StreetEvents

21 days ago

Q3 2024 Bio Rad Laboratories Inc Earnings Call

BIO

Morningstar Research

21 days ago

Analyst Report: Bio-Rad Laboratories, Inc.

BIO

MT Newswires

21 days ago

UBS Adjusts Price Target on Bio-Rad Laboratories to $390 From $400, Maintains Buy Rating

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

BIO

Business Wire

21 days ago

Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference

BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

BIO

Zacks

21 days ago

BIO Q3 Earnings and Revenues Surpass Estimates, Stock Up Aftermarket

Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...

BIO

GuruFocus.com

21 days ago

Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical Diagnostics ...

Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates

BIO

Zacks

22 days ago

Bio-Rad Laboratories (BIO) Beats Q3 Earnings and Revenue Estimates

BIO

Associated Press Finance

22 days ago

Bio-Rad: Q3 Earnings Snapshot

Bio-Rad Reports Third-Quarter 2024 Financial Results

BIO

Business Wire

22 days ago

Bio-Rad Reports Third-Quarter 2024 Financial Results

What to Expect From These 3 MedTech Stocks This Earnings Season

BIO

Zacks

23 days ago

What to Expect From These 3 MedTech Stocks This Earnings Season

Shareholders in Bio-Rad Laboratories (NYSE:BIO) have lost 58%, as stock drops 4.6% this past week

BIO

Simply Wall St.

a month ago

Shareholders in Bio-Rad Laboratories (NYSE:BIO) have lost 58%, as stock drops 4.6% this past week

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

BIO

Zacks

a month ago

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

FitLife Brands (FTLF) Soars 5.7%: Is Further Upside Left in the Stock?

BIO

Zacks

a month ago

FitLife Brands (FTLF) Soars 5.7%: Is Further Upside Left in the Stock?

BIO Gears Up for Q3 Earnings: Here's What You Need to Know

BIO

Zacks

a month ago

BIO Gears Up for Q3 Earnings: Here's What You Need to Know

Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund

BIO

Insider Monkey

a month ago

Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

BIO

Business Wire

a month ago

Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

BANK OF NOVA SCOTIA's Strategic Acquisition in Bio-Rad Laboratories Inc

BIO

GuruFocus.com

a month ago

BANK OF NOVA SCOTIA's Strategic Acquisition in Bio-Rad Laboratories Inc

BIO

Argus Research

a month ago

BIO: Raising target price to $274.00

Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

BIO

Zacks

2 months ago

Should You Continue to Hold Bio-Rad Stock in Your Portfolio?

BIO

MT Newswires

2 months ago

Citigroup Upgrades Bio-Rad Laboratories to Buy From Neutral, Adjusts Price Target to $400 From $350

Palantir Soars, Dell Pops As Big AI Plays Finally Get S&P 500 Nod

BIO

Investor's Business Daily

2 months ago

Palantir Soars, Dell Pops As Big AI Plays Finally Get S&P 500 Nod

Palantir and Dell Will Join S&P 500—What You Need To Know

BIO

Investopedia

2 months ago

Palantir and Dell Will Join S&P 500—What You Need To Know

Palantir Stock Jumps on S&P 500 Addition. Here’s Who Else Was Added.

BIO

Barrons.com

2 months ago

Palantir Stock Jumps on S&P 500 Addition. Here’s Who Else Was Added.

Palantir, Dell Will Finally Join The S&P 500. The Stocks Are Jumping.

BIO

Investor's Business Daily

2 months ago

Palantir, Dell Will Finally Join The S&P 500. The Stocks Are Jumping.

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

BIO

PR Newswire

2 months ago

Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Palantir, Dell Stocks Jump on S&P 500 Addition

BIO

Barrons.com

2 months ago

Palantir, Dell Stocks Jump on S&P 500 Addition

National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?

BIO

Zacks

2 months ago

National Vision (EYE) Down 6.9% Since Last Earnings Report: Can It Rebound?

BIO

MT Newswires

3 months ago

Wells Fargo Initiates Bio-Rad Laboratories at Equalweight With $340 Price Target

BIO

Argus Research

3 months ago

BIO: Raising target price to $283.00

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

BIO

Business Wire

3 months ago

Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference

Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now

BIO

Zacks

3 months ago

Reasons to Retain Bio-Rad (BIO) Stock in Your Portfolio Now

BIO

Argus Research

3 months ago

BIO: What does Argus have to say about BIO?

BIO

MT Newswires

3 months ago

Bio-Rad Laboratories Names Jon DiVincenzo COO

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

BIO

Business Wire

3 months ago

Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure

BIO

Zacks

3 months ago

Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure

Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?

BIO

Insider Monkey

3 months ago

Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?

BIO

MT Newswires

4 months ago

Citigroup Adjusts Price Target on Bio-Rad Laboratories to $350 From $300

BIO

MT Newswires

4 months ago

UBS Adjusts Price Target on Bio-Rad Laboratories to $400 From $385, Maintains Buy Rating

Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered

BIO

Zacks

4 months ago

Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered

BIO

MT Newswires

4 months ago

RBC Trims Price Target on Bio-Rad Laboratories to $401 From $402, Keeps Outperform Rating

BIO

MT Newswires

4 months ago

Bio-Rad Laboratories Q2 Earnings Up, Revenue Lower; Updates Guidance; Shares Fall After-Hours

Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates

BIO

Zacks

4 months ago

Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings Estimates

BIO

Associated Press Finance

4 months ago

Bio-Rad: Q2 Earnings Snapshot

Bio-Rad Reports Second-Quarter 2024 Financial Results

BIO

Business Wire

4 months ago

Bio-Rad Reports Second-Quarter 2024 Financial Results

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

BIO

Zacks

4 months ago

What's in Store for These 4 MedTech Stocks in Q2 Earnings?

All You Need to Know About Bio-Rad (BIO) Rating Upgrade to Buy

BIO

Zacks

4 months ago

All You Need to Know About Bio-Rad (BIO) Rating Upgrade to Buy

Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed

BIO

Insider Monkey

4 months ago

Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed

BIO

Argus Research

4 months ago

BIO: Lowering target price to $275.00

Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?

BIO

Zacks

4 months ago

Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

BIO

Business Wire

4 months ago

Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

BIO

Argus Research

4 months ago

BIO: Raising target price to $283.00

BIO

Argus Research

4 months ago

BIO: Raising target price to $220.00

BIO

MT Newswires

5 months ago

RBC Trims Price Target on Bio-Rad Laboratories to $402 From $414, Keeps Outperform Rating

Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?

BIO

Zacks

5 months ago

Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?

Is Bio-Rad Laboratories (BIO) a Lucrative Investment?

BIO

Insider Monkey

5 months ago

Is Bio-Rad Laboratories (BIO) a Lucrative Investment?

Italian energy company targets Britain for fleet of 20 mini-nukes

BIO

The Telegraph

5 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

BIO

Motley Fool

5 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

BIO

AFP

5 months ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

BIO

Simply Wall St.

5 months ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

BIO

Simply Wall St.

5 months ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

BIO

Simply Wall St.

5 months ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

BIO

Simply Wall St.

5 months ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

BIO

Motley Fool

5 months ago

3 Mistakes That Can Get Your Costco Membership Canceled

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

BIO

GuruFocus.com

5 months ago

Director Gregory Pipkin Sells 82,238 Shares of Sable Offshore Corp (SOC)

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

BIO

GuruFocus.com

5 months ago

Insider Sale: CFO Steven Tomsic Sells 30,000 Shares of Fox Corp (FOX)

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

BIO

GuruFocus.com

5 months ago

Insider Sale: Chief Legal Officer Jeff Lendino Sells Shares of Jamf Holding Corp (JAMF)

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

BIO

GuruFocus.com

5 months ago

Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)

Insider Sale: SVP & Chief Accounting Officer Dara Bazzano Sells 4,300 Shares of T-Mobile US ...

BIO

GuruFocus.com

5 months ago

Insider Sale: SVP & Chief Accounting Officer Dara Bazzano Sells 4,300 Shares of T-Mobile US ...

BIO

Motley Fool

5 months ago

What's Going On With Rivian Stock?

Director and 10% Owner Telekom Deutsche Sells Shares of T-Mobile US Inc (TMUS)

BIO

GuruFocus.com

5 months ago

Director and 10% Owner Telekom Deutsche Sells Shares of T-Mobile US Inc (TMUS)

Insider Sale: Director Donna Wells Sells Shares of Mitek Systems Inc (MITK)

BIO

GuruFocus.com

5 months ago

Insider Sale: Director Donna Wells Sells Shares of Mitek Systems Inc (MITK)

Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?

BIO

Zacks

5 months ago

Phibro (PAHC) Down 3.3% Since Last Earnings Report: Can It Rebound?

Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report?

BIO

Zacks

5 months ago

Why Is Bio-Rad (BIO) Up 7.8% Since Last Earnings Report?

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

BIO

Business Wire

6 months ago

Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

BIO

Business Wire

6 months ago

Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference

BIO

Thomson Reuters StreetEvents

6 months ago

Q1 2024 OncoCyte Corp Earnings Call

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results

BIO

Simply Wall St.

6 months ago

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results

BIO

Morningstar Research

6 months ago

Analyst Report: Bio-Rad Laboratories, Inc.

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down

BIO

Zacks

6 months ago

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down

BIO

MT Newswires

6 months ago

UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript

BIO

Insider Monkey

6 months ago

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript

BIO

MT Newswires

6 months ago

RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420

BIO

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Bio Rad Laboratories Inc Earnings Call

BIO

Associated Press Finance

6 months ago

Bio-Rad: Q1 Earnings Snapshot

Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market Challenges

BIO

GuruFocus.com

6 months ago

Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market Challenges

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

BIO

Zacks

6 months ago

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates

BIO

MT Newswires

6 months ago

Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline

BIO

Associated Press Finance

6 months ago

Bio-Rad: Q1 Earnings Snapshot

Bio-Rad Reports First-Quarter 2024 Financial Results

BIO

Business Wire

6 months ago

Bio-Rad Reports First-Quarter 2024 Financial Results

BIO

Morningstar Research

7 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Earnings Preview: National Vision (EYE) Q1 Earnings Expected to Decline

BIO

Zacks

7 months ago

Earnings Preview: National Vision (EYE) Q1 Earnings Expected to Decline

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

BIO

Business Wire

7 months ago

Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

BIO

Zacks

7 months ago

Latest Bio-Rad Laboratories Inc. (BIO) News on November 21, 2024

Share on Social Networks: